Display Settings:

Format

Send to:

Choose Destination
    Trends Endocrinol Metab. 2010 Apr;21(4):223-9. Epub 2009 Oct 26.

    Epigenetic mechanisms in the development of type 2 diabetes.

    Source

    Department of Pediatrics, The Children's Hospital Philadelphia, Philadelphia, PA 19104, USA.

    Abstract

    Type 2 diabetes (T2D) is a disorder of complex genetics influenced by interactions between susceptible genetic loci and environmental perturbations. Intrauterine growth retardation is one such environmental perturbation linked to the development of T2D in adulthood. An abnormal metabolic intrauterine milieu affects fetal development by permanently modifying expression of key genes regulating beta-cell development (Pdx1) and glucose transport (Glut4) in muscle. Epigenetic regulation of gene expression is one mechanism by which genetic susceptibility and environmental insults can lead to T2D. Therefore, therapeutic agents targeting epigenetic gene regulation can ultimately be used to treat T2D; however, there is much to be learned about genome-wide epigenetic programming of health and disease before these therapies can be used in patient care.

    Copyright 2009 Elsevier Ltd. All rights reserved.

    PMID:
    19864158
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2848901
    Free PMC Article

    Images from this publication.See all images (2) Free text

    Figure 2
    Figure 1

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk